The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer
- 13 March 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (6), 1293-1303
- https://doi.org/10.1158/0008-5472.can-19-1027
Abstract
Small-cell lung cancer (SCLC) is an aggressive form of lung cancer with dismal survival rates. While kinases often play key roles driving tumorigenesis, there are strikingly few kinases known to promote the development of SCLC. Here, we investigated the contribution of the MAPK module MEK5–ERK5 to SCLC growth. MEK5 and ERK5 were required for optimal survival and expansion of SCLC cell lines in vitro and in vivo. Transcriptomics analyses identified a role for the MEK5–ERK5 axis in the metabolism of SCLC cells, including lipid metabolism. In-depth lipidomics analyses showed that loss of MEK5/ERK5 perturbs several lipid metabolism pathways, including the mevalonate pathway that controls cholesterol synthesis. Notably, depletion of MEK5/ERK5 sensitized SCLC cells to pharmacologic inhibition of the mevalonate pathway by statins. These data identify a new MEK5–ERK5–lipid metabolism axis that promotes the growth of SCLC. Significance: This study is the first to investigate MEK5 and ERK5 in SCLC, linking the activity of these two kinases to the control of cell survival and lipid metabolism.Other Versions
Funding Information
- Department of Defense (W81XWH-15-1-0250)
- NIH (R01CA206540, R01CA201513, U01CA213273, R35CA231997)
- NIH (F31CA206346)
- NIH (3P50HG00773505S1)
This publication has 56 references indexed in Scilit:
- MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent TumorigenesisPLOS ONE, 2013
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Targeting tumor cell metabolism with statinsOncogene, 2012
- A crucial requirement for Hedgehog signaling in small cell lung cancerNature Medicine, 2011
- Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 PathwayThe Journal of Immunology, 2010
- Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cellsMolecular Cancer Therapeutics, 2006
- Regulation of cellular functions by the ERK5 signalling pathwayCellular Signalling, 2006
- Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signallingOncogene, 2005
- Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genesProceedings of the National Academy of Sciences of the United States of America, 2003
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study)The American Journal of Cardiology, 1998